Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Energy Transfer Partners
ET
|
+$560M |
| 2 |
Apple
AAPL
|
+$375M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$354M |
| 4 |
Alibaba
BABA
|
+$275M |
| 5 |
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
|
+$263M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$1.83B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$703M |
| 3 |
ETP
Energy Transfer Partners, L.P.
ETP
|
+$677M |
| 4 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$297M |
| 5 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$291M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.78% |
| 2 | Financials | 5.08% |
| 3 | Healthcare | 4.24% |
| 4 | Consumer Discretionary | 4.16% |
| 5 | Energy | 3.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4326
Triumph Financial Inc
TFIN
$1.83B
| $394K | ﹤0.01% |
13,273
-1,160
| -8% | -$40.9K |
|
4327
Vanguard S&P 500 Growth ETF
VOOG
$26.4B
| $394K | ﹤0.01% |
17,490
-900
| -5% | -$21.8K |
|
|
TVRD
4328
PUT
Tvardi Therapeutics
TVRD
$19M
| $394K | ﹤0.01% |
842
-114
| -12% | -$73.5K |
|
|
DCOM
4329
DELISTED
Dime Community Bancshares
DCOM
| $394K | ﹤0.01% |
23,223
+1,827
| +9% | +$31.1K |
|
4330
SPX Corp
SPXC
$10.7B
| $392K | ﹤0.01% |
13,997
-13,277
| -49% | -$388K |
|
4331
Clear Channel Outdoor Holdings
CCO
$1.23B
| $391K | ﹤0.01% |
75,187
-174
| -0.2% | -$980 |
|
4332
Huron Consulting
HURN
$2.39B
| $391K | ﹤0.01% |
7,617
+86
| +1% | +$4.37K |
|
|
BCPC
4333
Balchem Corp
BCPC
$5.58B
| $391K | ﹤0.01% |
4,995
+3,117
| +166% | +$281K |
|
|
TRTN
4334
CALL
DELISTED
Triton International Limited
TRTN
| $391K | ﹤0.01% |
12,600
-4,200
| -25% | -$135K |
|
4335
CALL
Burlington
BURL
$23.2B
| $390K | ﹤0.01% |
2,400
-2,000
| -45% | -$323K |
|
4336
CALL
SolarEdge
SEDG
$2.74B
| $390K | ﹤0.01% |
11,100
-5,200
| -32% | -$199K |
|
|
PTLA
4337
CALL
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $390K | ﹤0.01% |
20,000
+12,200
| +156% | +$251K |
|
4338
Equinor
EQNR
$94.8B
| $388K | ﹤0.01% |
18,357
-662
| -3% | -$16.2K |
|
4339
CALL
ING
ING
$101B
| $388K | ﹤0.01% |
36,400
+23,900
| +191% | +$287K |
|
4340
Avient
AVNT
$3.43B
| $387K | ﹤0.01% |
13,536
-8,752
| -39% | -$293K |
|
4341
IAMGOLD
IAG
$8.53B
| $386K | ﹤0.01% |
105,028
+32,804
| +45% | +$115K |
|
4342
PUT
Wabtec
WAB
$50.1B
| $386K | ﹤0.01% |
5,500
| – | – |
|
4343
CALL
W.P. Carey
WPC
$16.6B
| $386K | ﹤0.01% |
6,024
+4,186
| +228% | +$272K |
|
|
FSB
4344
DELISTED
Franklin Financial Network, Inc.
FSB
| $386K | ﹤0.01% |
14,653
+7,185
| +96% | +$238K |
|
|
TPGH.U
4345
DELISTED
TPG Pace Holdings Corp. Units, each consisting of one Class A ordinary share, $.0001 par value, and
TPGH.U
| $386K | ﹤0.01% |
+37,023
| New | +$389K |
|
4346
Enerpac Tool Group
EPAC
$1.85B
| $385K | ﹤0.01% |
18,331
-10,852
| -37% | -$264K |
|
4347
Invesco S&P International Developed Quality ETF
IDHQ
$940M
| $385K | ﹤0.01% |
18,855
+18,705
| +12,470% | +$400K |
|
4348
PUT
Prothena Corp
PRTA
$436M
| $385K | ﹤0.01% |
37,400
-7,700
| -17% | -$91.5K |
|
|
NTUS
4349
DELISTED
Natus Medical Inc
NTUS
| $385K | ﹤0.01% |
11,323
+789
| +7% | +$25.7K |
|
|
MITT
4350
TPG Mortgage Investment Trust
MITT
$227M
| $384K | ﹤0.01% |
8,024
-156
| -2% | -$8.18K |
|
Similar funds
Citigroup's Q4 2018 Portfolio in Review
As of Q4 2018, Citigroup held 8,079 positions worth $98.7B, down 12% from $112B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Citigroup deployed $3.55B of net new capital in Q4 2018, opening 273 new positions and adding to 3,486 existing holdings. Its largest new stake was Takeda Pharmaceutical: 6,548,306 shares worth $113M.
By sector, the portfolio is most concentrated in Technology at 5.8% of assets, up from 5.1% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $1.83B trimmed.
- Citigroup's largest Q4 2018 buy was Takeda Pharmaceutical: 6,548,306 shares worth $113M.
- Citigroup added most to Energy Transfer Partners in Q4 2018, an estimated $560M increase.
- Citigroup's biggest Q4 2018 reduction was iShares Russell 2000 ETF, cutting an estimated $1.83B.
- Citigroup fully exited Energy Transfer Partners, L.P. in Q4 2018, selling an estimated $677M.
- Citigroup's ten largest holdings make up 17% of its $98.7B portfolio in Q4 2018.
- Citigroup opened 273 new positions and closed 357 in Q4 2018.
- Citigroup's portfolio value fell 12% quarter-over-quarter to $98.7B.
Based on Citigroup's 13F filing for Q4 2018, filed 12 Feb 2019.